Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,063,591
+$1,223,491 QoQ
Shares Held
17,457
+161.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $18,364,187 across 30 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
489,799 | $6,783,716 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
127,505 | $2,361,392 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
17,457 | $2,063,591 | |
| 4 | HLN |
Haleon plc
|
118,327 | $1,184,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
7,689 | $1,012,948 | |
| 6 | VTRS |
Viatris Inc
|
70,339 | $950,279 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,340 | $733,120 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
7,890 | $598,456 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,063,591 | 17,457 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $840,100 | 6,677 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,400,964 | 16,409 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,965,905 | 12,606 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,013,340 | 12,228 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $965,034 | 5,923 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,172,866 | 6,003 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,035,652 | 5,974 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $935,731 | 5,530 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,178,298 | 5,970 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,011,693 | 5,815 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $949,738 | 5,515 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $930,233 | 5,589 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $681,750 | 4,652 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $717,130 | 4,836 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $877,326 | 5,104 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $867,514 | 4,600 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,142,060 | 4,680 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $894,402 | 4,607 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $865,083 | 4,642 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $765,510 | 4,861 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $767,589 | 4,638 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $762,190 | 4,609 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $755,912 | 5,516 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $891,948 | 7,579 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||